J A Kemp LLP
An EPO opposition provides a cost-effective route to attack a European patent in a single action following grant. Even though the new Unified Patent Court could allow opponents to challenge...
J A Kemp LLP
The UPC preparatory committee has recently published a timeline which indicates that the UPC will come into existence on 1 April 2023.
J A Kemp LLP
Therapies based on small interfering RNAs (siRNAs) have recently hit the headlines with one drug effecting significant clinical improvements in patients suffering from motor neuron disease.
J A Kemp LLP
The European Patent Office (EPO) is well known for taking an extremely strict approach when assessing the allowability of amendments made to patent applications during examination...
J A Kemp LLP
Bringing a PCT application into the national/regional phase involves taking a large number of decisions simultaneously.
J A Kemp LLP
Bringing a PCT application into the national/regional phase involves taking a large number of decisions simultaneously.
J A Kemp LLP
The European Patent Office (EPO) is well known for taking an extremely strict approach when assessing the allowability of amendments made to patent applications during examination and to patents during opposition.
J A Kemp LLP
This year’s IAM Patent 1000 says that “J A Kemp stands as one of the top patent prosecution practices in Europe, dominating the UK market and making a continental impact...
J A Kemp LLP
Ravi Srinivasan, Head of J A Kemp's pharmaceutical practice, has been named "Practitioner of the Year" at the Managing Intellectual Property (MIP) Awards.
J A Kemp LLP
J A Kemp’s Cambridge office has won the “Intellectual Property/IT Team of the Year” category in the Cambridgeshire Law Society (CLS) Legal Excellence Awards 2022.